Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Product Approvals and Interventional Clinical
4.1.1.2. Market Developments
4.1.2. Restraints
4.1.2.1. High Cost
4.1.2.2. Lack of Treatment Options
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. By Treatment
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Segment
7.1.2. Market Attractiveness Index, By Treatment Segment
7.2. Surgery
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Growth Hormone Therapy
8. By End User
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User Segment
8.1.2. Market Attractiveness Index, By End User Segment
8.2. Hospitals And Clinics
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Home Care Setting
8.4. Other
9. By Region
9.1. Introduction
9.1.1. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
9.1.2. Market Attractiveness Index, By Region
9.2. North America
9.2.1. Introduction
9.2.2. Key Region-Specific Dynamics
9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment
9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.2.5.1. The U.S.
9.2.5.2. Canada
9.2.5.3. Mexico
9.3. Europe
9.3.1. Introduction
9.3.2. Key Region-Specific Dynamics
9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment
9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.3.5.1. Germany
9.3.5.2. The U.K.
9.3.5.3. France
9.3.5.4. Italy
9.3.5.5. Spain
9.3.5.6. Rest of Europe
9.4. South America
9.4.1. Introduction
9.4.2. Key Region-Specific Dynamics
9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment
9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.4.5.1. Brazil
9.4.5.2. Argentina
9.4.5.3. Rest of South America
9.5. Asia Pacific
9.5.1. Introduction
9.5.2. Key Region-Specific Dynamics
9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment
9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
9.5.5.1. China
9.5.5.2. India
9.5.5.3. Japan
9.5.5.4. Australia
9.5.5.5. Rest of Asia Pacific
9.6. Middle East and Africa
9.6.1. Introduction
9.6.2. Key Region-Specific Dynamics
9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment
9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
10. Competitive Landscape
10.1. Key Developments and Strategies
10.2. Company Share Analysis
10.3. Product Benchmarking
11. Company Profiles
11.1. Pfizer
11.1.1. Company Overview
11.1.2. Product Portfolio and Description
11.1.3. Key Highlights
11.1.4. Financial Overview
11.2. Sandoz International GmbH
11.3. Sanofi-Aventis
11.4. Novo Nordisk A/S
11.5. Teva Pharmaceutical Industries Limited
11.6. Ranbaxy
11.7. EMD Serono, Inc.
11.8. Sun Pharmaceutical Industries Ltd.
11.9. Eli Lilly and Company
11.10. Ferring Holding SA
11.11. Genentech, Inc.
11.12. Merck & Co., Inc.
11.13. Ipsen
11.14. GeneScience Pharmaceuticals Co., Ltd.
11.15. Roche Holdings, Inc.
LIST NOT EXHAUSTIVE
12. DataM
12.1. Appendix
12.2. About Us and Services
12.3. Contact Us